The state of New York plans to invest $1 billion in SUNY Downstate’s hospital in New York City’s Brooklyn borough. The investment comes after months of community engagement led by SUNY Downstate’s Community Advisory Board and concerns about the $100…
The Latest
Here are three of the most recent recalls reported to the FDA in June: Q’Apel Medical recalled its Hippo 072 aspiration system, including the Cheetah delivery tool and aspiration tubing, following a FDA warning letter. The devices, used for removing…
Florida Attorney General James Uthmeier has taken legal action against Contec, a Chinese medical devicemaker, and Miami-based reseller Epsimed, alleging the companies sold patient monitors that pose cybersecurity risks and misled customers about safety. According to a June 16 news…
Hospital labor costs related to drug shortage management have significantly increased, from $359 million in 2019 to $894 million in 2024 — a nearly 150% increase, according to a Vizient report published June 17. Vizient surveyed 132 of its clients…
An Orlando, Fla.-based Advent Health surgeon has performed a prostatectomy via transcontinental robotic telesurgery — the first of an FDA-approved clinical trial to test the technology, according to a June 17 ABC News report. The patient lives in the nation…
As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind immunotherapy response and resistance. Here are three recent immunotherapy research initiatives:
Anthony Law, MD, PhD, an assistant professor in the department of otolaryngology at Atlanta-based Emory University School of Medicine, has developed an AI model to detect throat cancer in a patient’s voice. The AI model, a deep neural network, was…
Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,0001 fatalities expected in 2025. While the burden of this disease is significant, advancements in treatment and technology offer new opportunities for prevention, early detection…
The FDA has delayed its decision to approve a new treatment for hereditary angioedema, citing a heavy workload and limited resources. The drug, sebetralstat, developed by Kalvista Pharmaceuticals, was scheduled for a decision by June 17 under the Prescription Drug…
Mark Cuban’s Cost Plus Drug Co. and virtual care provider 9amHealth have partnered to offer obesity medications through a new program targeting self-insured employers. Under the partnership, 9amHealth will use low-cost oral obesity medications sourced from Cost Plus Drugs alongside…